A Biobehavioral Intervention for Young Men With Testicular Cancer

Status Recruiting

Clinical Trial Summary

This study is a randomized controlled biobehavioral pilot trial designed to investigate the feasibility and preliminary efficacy of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. Participants will be randomized to receive six sessions of GET or Individual Supportive Therapy (ISP) delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1) and twelve weeks after intervention at T2. Additionally, identified biomarkers will be measured at baseline and at T2.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04150848
Study type	Interventional
Source	University of California, Irvine
Contact	Michael A Hoyt, PhD
Phone	949-824-9937
Email	mahoyt@uci.edu
Status	Recruiting
Phase	Phase 2
Start date	November 1, 2018
Completion date	December 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04028479` - The Registry of Oncology Outcomes Associated With Testing and Treatment
Terminated	`NCT02689219` - Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors	Phase 2
Completed	`NCT03880994` - Mental Health of Men Before and After Testicular Cancer Treatment
Active, not recruiting	`NCT03426865` - Role of Axumin PET Scan in Germ Cell Tumor
Completed	`NCT02429466` - Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors	Phase 1
Recruiting	`NCT06357416` - The Man Van Project	N/A